Alicja Kasperska-Zajac

Summary

Affiliation: Medical University of Silesia
Country: Poland

Publications

  1. Kasperska Zajac A, Brzoza Z, Rogala B. Lower serum concentration of dehydroepiandrosterone sulphate in patients suffering from chronic idiopathic urticaria. Allergy. 2006;61:1489-90 pubmed
  2. Kasperska Zajac A, Brzoza Z, Rogala B. Platelet activating factor as a mediator and therapeutic approach in bronchial asthma. Inflammation. 2008;31:112-20 pubmed publisher
    ..This review will focus on two main issues: the role of PAF and PAF antagonists in asthma. ..
  3. Kasperska Zajac A, Brzoza Z, Rogala B. Platelet-activating factor (PAF): a review of its role in asthma and clinical efficacy of PAF antagonists in the disease therapy. Recent Pat Inflamm Allergy Drug Discov. 2008;2:72-6 pubmed
    ..This review is a brief summary of relevant scientific basis as well as clinical research on the role of PAF in asthma, the significance of anti-PAF therapy in the disease, as well as US. patents (1998-2002) related to PAF antagonists. ..
  4. Kasperska Zajac A, Grzanka A, Machura E, Mazur B, Misiolek M, Czecior E, et al. Analysis of procalcitonin and CRP concentrations in serum of patients with chronic spontaneous urticaria. Inflamm Res. 2013;62:309-12 pubmed publisher
    ..PCT should be considered as a better marker than CRP to distinguish between APR to infection and an active non-specific urticarial inflammation. ..
  5. Kasperska Zajac A, Brzoza Z, Rogala B. Platelet function in cutaneous diseases. Platelets. 2008;19:317-21 pubmed publisher
    ..Considering the risk of cardiovascular events, some of them seem to be of clinical significance. This contribution is a brief outline of the present knowledge of the platelet function in dermal disorders. ..
  6. Kasperska Zajac A. Acute-phase response in chronic urticaria. J Eur Acad Dermatol Venereol. 2012;26:665-72 pubmed publisher
    ..This review summarizes information regarding APR in the course of urticaria/angio-oedema. ..
  7. Kasperska Zajac A, Nowakowski M, Rogala B. Enhanced platelet activation in patients with atopic eczema/dermatitis syndrome. Inflammation. 2004;28:299-302 pubmed
    ..The results suggest that some patients with AEDS may have enhanced blood platelet activity as expressed by beta-TG and PF4 level. ..
  8. Kasperska Zajac A, Brzoza Z, Rogala B. Effect of allergen-specific immunotherapy on platelet secretory activity in patients with grass-pollen allergy. Vaccine. 2006;24:6990-3 pubmed
    ..In particular, it seems that both early (after 30 min) and late (after 24 h) changes in plasma level of this marker do not occur following the maximum dose administration of the allergen vaccine during the early SIT phase. ..
  9. Kasperska Zajac A, Brzoza Z, Rogala B. Plasma concentration of interleukin 6 (IL-6), and its relationship with circulating concentration of dehydroepiandrosterone sulfate (DHEA-S) in patients with chronic idiopathic urticaria. Cytokine. 2007;39:142-6 pubmed
    ..However, no association between IL-6 and DHEA-S concentration in the peripheral circulation of CIU patients was proved, suggesting that both phenomena may not be related to each other. ..

More Information

Publications15

  1. Kasperska Zajac A, Alicja K. Recovery of platelet factor 4 (PF-4) and beta-thromboglobulin (beta-TG) plasma concentrations during remission in patients suffering from atopic dermatitis. Platelets. 2010;21:522-4 pubmed publisher
    ..As with earlier data, the findings point to platelet activity in AD increasing during flare, falling following therapy and normalizing upon remission. ..
  2. Kasperska Zajac A, Brzoza Z, Rogala B. Increased concentration of platelet-derived chemokines in serum of patients with delayed pressure urticaria. Eur Cytokine Netw. 2008;19:89-91 pubmed publisher
  3. Kasperska Zajac A, Czecior E, Namyslowski G. Effect of tonsillectomy on the level of exhaled nitric oxide (NO) in patients with recurrent tonsillitis. Respir Med. 2010;104:1757-9 pubmed publisher
  4. Kasperska Zajac A, Sztylc J, Machura E, Jop G. Plasma IL-6 concentration correlates with clinical disease activity and serum C-reactive protein concentration in chronic urticaria patients. Clin Exp Allergy. 2011;41:1386-91 pubmed publisher
    ..Such acute-phase response is manifested by increased circulating IL-6, which varies along with CRP changes and may be related to the urticarial activity. ..
  5. Kasperska Zajac A, Grzanka A, Czecior E, Misiolek M, Rogala B, Machura E. Acute phase inflammatory markers in patients with non-steroidal anti-inflammatory drugs (NSAIDs)-induced acute urticaria/angioedema and after aspirin challenge. J Eur Acad Dermatol Venereol. 2013;27:1048-52 pubmed publisher
    ..The study supports the evidence proving that up-regulation of CRP and IL-6 in urticaria/angioedema does not necessarily reflect any concomitant infection or other inflammatory processes, but may be due to the disease itself. ..
  6. Kasperska Zajac A, Jasinska T, Grzanka A, Kowalik Sztylc A. Markers of systemic inflammation in delayed pressure urticaria. Int J Dermatol. 2013;52:309-10 pubmed publisher
    ..This indicates that the disease induces a systemic inflammatory process, termed the acute phase response. ..